Note: Ingredients listed on restricted chemical lists
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
86.5
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
<1
General Information
Revision date
2021-03-25
Product name
NIGHT NURSE CAPSULES
Product Synonyms
FP-SK/153 * FP-SK/154 * NIGHT NURSE CAPSULES * DAY AND NIGHT NURSE CAPSULES *
1.2.2. Uses advised against
No other uses are advised Details of principal suppliers
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity (oral) Category 4 Skin corrosion or irritation Category 2 Serious eye damage or eye irritation Category 2 Skin sensitisation Category 1
Environmental hazards
Hazardous to the aquatic environment - Category 3 chronic hazard
Signal word
Warning
Hazard statements
Harmful if swallowed. Causes skin irritation. May cause allergic skin reaction. Causes serious eye irritation. Harmful to aquatic life with long lasting effects.
Prevention
Avoid breathing dust. Do not eat, drink, or smoke when using this product. Contaminated work clothing shall not be allowed out of the workplace. Avoid release to the environment. Wear eye protection/face protection. Wear protective gloves.
Response
IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell. Rinse mouth. IF ON SKIN Wash with plenty of water. IF IN EYES Rinse cautiously with water for several minutes Remove contact lenses, if present and easy to do. Continue rinsing. Specific treatment (see on this label). If skin irritation or rash occurs Get medical advice/attention. If eye irritation persists Get medical advice/attention. Take off contaminated clothing and wash before reuse.
Storage
Not available.
Disposal
Not available.
Other hazards which do not result in classification
Assume that this material is capable of sustaining combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
99.9 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99.9 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 11.7 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 10.4 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. Section 3: Composition and information of the ingredients of the hazardous chemical
